NanoString Technologies Stock Price, News & Analysis (NASDAQ:NSTG)

$6.90 +0.06 (+0.88 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$6.90
Today's Range$6.70 - $6.95
52-Week Range$6.31 - $20.70
Volume57,565 shs
Average Volume124,602 shs
Market Capitalization$173.62 million
P/E Ratio-3.33
Dividend YieldN/A
Beta0.78

About NanoString Technologies (NASDAQ:NSTG)

NanoString Technologies logoNanoString Technologies, Inc. develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. The Company's nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology. The Company markets systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of diseases, such as cancer, and to clinical laboratories and medical centers for diagnostic use.

Receive NSTG News and Ratings via Email

Sign-up to receive the latest news and ratings for NSTG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic & Testing Substances
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:NSTG
CUSIPN/A
Phone206-378-6266

Debt

Debt-to-Equity Ratio1.08%
Current Ratio3.35%
Quick Ratio2.89%

Price-To-Earnings

Trailing P/E Ratio-3.33333333333333
Forward P/E Ratio-3.63
P/E GrowthN/A

Sales & Book Value

Annual Sales$86.49 million
Price / Sales2.02
Cash FlowN/A
Price / CashN/A
Book Value$0.59 per share
Price / Book11.69

Profitability

Trailing EPS($2.07)
Net Income$-47,080,000.00
Net Margins-44.24%
Return on Equity-174.55%
Return on Assets-34.82%

Miscellaneous

Employees407
Outstanding Shares25,380,000

NanoString Technologies (NASDAQ:NSTG) Frequently Asked Questions

What is NanoString Technologies' stock symbol?

NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."

How were NanoString Technologies' earnings last quarter?

NanoString Technologies Inc (NASDAQ:NSTG) posted its quarterly earnings results on Thursday, November, 2nd. The biotechnology company reported ($0.45) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.56) by $0.11. The biotechnology company earned $27.02 million during the quarter, compared to analyst estimates of $26.27 million. NanoString Technologies had a negative net margin of 44.24% and a negative return on equity of 174.55%. The company's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.51) earnings per share. View NanoString Technologies' Earnings History.

When will NanoString Technologies make its next earnings announcement?

NanoString Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, March, 7th 2018. View Earnings Estimates for NanoString Technologies.

Where is NanoString Technologies' stock going? Where will NanoString Technologies' stock price be in 2018?

4 brokerages have issued 12-month target prices for NanoString Technologies' stock. Their predictions range from $12.00 to $20.00. On average, they anticipate NanoString Technologies' share price to reach $17.33 in the next year. View Analyst Ratings for NanoString Technologies.

Who are some of NanoString Technologies' key competitors?

Who are NanoString Technologies' key executives?

NanoString Technologies' management team includes the folowing people:

  • William D. Young, Independent Chairman of the Board
  • R. Bradley Gray, President, Chief Executive Officer, Director
  • K. Thomas Bailey, Chief Financial Officer, Treasurer
  • J. Chad Brown, Senior Vice President - Sales and Marketing
  • , Bio & Compensation - 
  • Mary Tedd Allen, Senior Vice President - Operations
  • Joseph M. Beechem Ph.D., Senior Vice President - Research and Development
  • David W. Ghesquiere, Senior Vice President - Corporate & Business Development
  • Elisha W. Finney, Director
  • Nicholas G. Galakatos Ph.D., Independent Director
  • Robert M. Hershberg M.D. Ph.D., Independent Director

Who owns NanoString Technologies stock?

NanoString Technologies' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.25%), Levin Capital Strategies L.P. (5.02%), ARK Investment Management LLC (4.49%), Millennium Management LLC (3.96%), Altrinsic Global Advisors LLC (1.90%) and Renaissance Technologies LLC (0.76%). Company insiders that own NanoString Technologies stock include Barney Saunders, Charles P Waite Jr, David W Ghesquiere, James A Johnson, R Bradley Gray and Wayne Burns. View Institutional Ownership Trends for NanoString Technologies.

Who sold NanoString Technologies stock? Who is selling NanoString Technologies stock?

NanoString Technologies' stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Spark Investment Management LLC, Renaissance Technologies LLC, Algert Global LLC, Tekla Capital Management LLC, TIAA CREF Investment Management LLC, Candriam Luxembourg S.C.A. and Millennium Management LLC. Company insiders that have sold NanoString Technologies company stock in the last year include David W Ghesquiere and R Bradley Gray. View Insider Buying and Selling for NanoString Technologies.

Who bought NanoString Technologies stock? Who is buying NanoString Technologies stock?

NanoString Technologies' stock was bought by a variety of institutional investors in the last quarter, including ARK Investment Management LLC, Levin Capital Strategies L.P., Altrinsic Global Advisors LLC, Broadfin Capital LLC, Alambic Investment Management L.P., Two Sigma Investments LP, Deutsche Bank AG and Baird Financial Group Inc.. View Insider Buying and Selling for NanoString Technologies.

How do I buy NanoString Technologies stock?

Shares of NanoString Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NanoString Technologies' stock price today?

One share of NanoString Technologies stock can currently be purchased for approximately $6.90.

How big of a company is NanoString Technologies?

NanoString Technologies has a market capitalization of $173.62 million and generates $86.49 million in revenue each year. The biotechnology company earns $-47,080,000.00 in net income (profit) each year or ($2.07) on an earnings per share basis. NanoString Technologies employs 407 workers across the globe.

How can I contact NanoString Technologies?

NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH, SEATTLE WA, 98109. The biotechnology company can be reached via phone at 206-378-6266 or via email at [email protected]


MarketBeat Community Rating for NanoString Technologies (NSTG)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  157 (Vote Outperform)
Underperform Votes:  140 (Vote Underperform)
Total Votes:  297
MarketBeat's community ratings are surveys of what our community members think about NanoString Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

NanoString Technologies (NASDAQ:NSTG) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.252.252.252.50
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $17.33$17.33$17.33$20.00
Price Target Upside: 77.23% upside77.23% upside77.23% upside24.15% upside

NanoString Technologies (NASDAQ:NSTG) Consensus Price Target History

Price Target History for NanoString Technologies (NASDAQ:NSTG)

NanoString Technologies (NASDAQ:NSTG) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017Robert W. BairdLower Price TargetOutperform$14.00 -> $12.00N/AView Rating Details
10/12/2017Janney Montgomery ScottDowngradeBuy -> NeutralN/AView Rating Details
10/12/2017CowenDowngradeOutperform -> Market PerformN/AView Rating Details
4/20/2017Morgan StanleyDowngradeOverweight -> Equal Weight$23.00 -> $20.00HighView Rating Details
8/5/2016BTIG ResearchReiterated RatingBuy$20.00N/AView Rating Details
(Data available from 2/24/2016 forward)

Earnings

NanoString Technologies (NASDAQ:NSTG) Earnings History and Estimates Chart

Earnings by Quarter for NanoString Technologies (NASDAQ:NSTG)

NanoString Technologies (NASDAQ NSTG) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2018($0.42)N/AView Earnings Details
2/27/2018($0.44)N/AView Earnings Details
11/2/2017Q3 2017($0.56)($0.45)$26.27 million$27.02 millionViewN/AView Earnings Details
8/8/2017Q2 2017($0.37)($0.20)$29.87 million$34.59 millionViewListenView Earnings Details
5/4/2017Q1 2017($0.87)($0.87)$17.53 million$18.10 millionViewListenView Earnings Details
3/1/2017Q4 2016($0.52)($0.55)$24.90 million$25.23 millionViewListenView Earnings Details
11/2/2016Q316($0.52)($0.51)$23.46 million$23.90 millionViewN/AView Earnings Details
8/3/2016Q2($0.66)($0.55)$19.62 million$22.60 millionViewN/AView Earnings Details
5/5/2016Q1($0.69)($0.74)$14.92 million$14.70 millionViewN/AView Earnings Details
2/29/2016Q4($0.54)($0.44)$21.12 million$22.30 millionViewN/AView Earnings Details
11/2/2015Q315($0.50)($0.49)$15.44 million$15.70 millionViewListenView Earnings Details
8/4/2015Q215($0.57)($0.66)$12.80 million$13.10 millionViewN/AView Earnings Details
5/6/2015Q115($0.58)($0.81)$12.10 million$11.59 millionViewN/AView Earnings Details
2/24/2015Q4 2014($0.60)$15.55 million$14.22 millionViewN/AView Earnings Details
11/4/2014Q314($0.56)($0.54)$11.80 million$12.30 millionViewN/AView Earnings Details
8/5/2014Q214($0.71)($0.58)$10.20 million$10.90 millionViewN/AView Earnings Details
5/7/2014Q114($0.70)($0.56)$8.37 million$8.70 millionViewN/AView Earnings Details
2/26/2014Q4($0.89)($0.60)$9.61 million$10.10 millionViewN/AView Earnings Details
11/5/2013Q3 2013($0.67)($0.53)$7.67 million$8.39 millionViewN/AView Earnings Details
8/6/2013Q2 2013($0.78)($0.67)$6.80 million$7.22 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

NanoString Technologies (NASDAQ:NSTG) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.9 EPS
Next Year EPS Consensus Estimate: $-2.19 EPS

Dividends

Dividend History for NanoString Technologies (NASDAQ:NSTG)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

NanoString Technologies (NASDAQ NSTG) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 24.40%
Institutional Ownership Percentage: 99.52%
Insider Trades by Quarter for NanoString Technologies (NASDAQ:NSTG)
Insider Trades by Quarter for NanoString Technologies (NASDAQ:NSTG)

NanoString Technologies (NASDAQ NSTG) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/13/2017David W GhesquiereSVPSell689$8.14$5,608.4617,327View SEC Filing  
4/3/2017R Bradley GrayInsiderSell1,100$20.58$22,638.0075,785View SEC Filing  
12/6/2016Wayne BurnsSVPSell21,666$22.04$477,518.6471,034View SEC Filing  
11/21/2016Charles P Waite JrDirectorSell588,024$21.25$12,495,510.001,707View SEC Filing  
11/11/2016Barney SaundersSVPSell11,983$22.48$269,377.846,371View SEC Filing  
11/11/2016James A JohnsonCFOSell10,000$22.57$225,700.0010,698View SEC Filing  
11/11/2016R Bradley GrayInsiderSell37,325$22.49$839,439.2579,428View SEC Filing  
10/26/2016Charles P Waite JrDirectorSell42,489$20.56$873,573.841,707View SEC Filing  
9/8/2016Charles P Waite JrDirectorSell29,105$16.51$480,523.551,707View SEC Filing  
9/7/2016Wayne BurnsSVPSell3,961$16.50$65,356.5059,704View SEC Filing  
8/30/2016Charles P Waite JrDirectorSell111,060$16.57$1,840,264.201,707View SEC Filing  
8/25/2016Charles P Waite JrDirectorSell40,363$16.59$669,622.171,707View SEC Filing  
8/22/2016Charles P Waite JrDirectorSell72,145$16.61$1,198,328.451,707View SEC Filing  
8/16/2016Charles P Waite JrDirectorSell257,698$16.55$4,264,901.901,707View SEC Filing  
3/2/2016David W GhesquiereSVPSell1,321$14.86$19,630.062,521View SEC Filing  
8/13/2015Wayne BurnsSVPSell30,000$14.93$447,900.00View SEC Filing  
12/2/2014Barney SaundersSVPSell30,000$14.93$447,900.00View SEC Filing  
11/14/2014Charles P Waite JrDirectorSell14,632$12.25$179,242.00View SEC Filing  
9/8/2014Charles P Waite JrDirectorSell45,000$11.21$504,450.00View SEC Filing  
9/5/2014Charles P Waite JrDirectorSell86,942$11.17$971,142.14View SEC Filing  
9/3/2014Ovp Venture Partners Vi LpMajor ShareholderSell35,000$11.15$390,250.00View SEC Filing  
8/19/2014Charles P Waite JrDirectorSell1,700$12.01$20,417.00View SEC Filing  
8/19/2014Ovp Venture Partners Vi LpMajor ShareholderSell20,257$12.05$244,096.85View SEC Filing  
8/18/2014Charles P Waite JrDirectorSell18,557$12.05$223,611.85View SEC Filing  
8/18/2014Ovp Venture Partners Vi LpMajor ShareholderSell11,925$12.05$143,696.25View SEC Filing  
8/15/2014Ovp Venture Partners Vi LpMajor ShareholderSell28,801$12.36$355,980.36View SEC Filing  
6/13/2014Charles P Waite JrDirectorSell166,755$15.08$2,514,665.40View SEC Filing  
6/13/2014Wayne BurnsSVPSell4,900$15.01$73,549.00View SEC Filing  
6/12/2014Barney SaundersSVPSell28,000$15.04$421,120.00View SEC Filing  
6/10/2014Ovp Venture Partners Vi LpMajor ShareholderSell160,000$15.48$2,476,800.00View SEC Filing  
6/9/2014Wayne BurnsSVPSell20,100$15.76$316,776.00View SEC Filing  
7/1/2013Lifesciences Ii L.P. ClarusMajor ShareholderBuy750,000$10.00$7,500,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

NanoString Technologies (NASDAQ NSTG) News Headlines

Source:
DateHeadline
NanoString Technologies to Release Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call on Wednesday, March 7, 2018NanoString Technologies to Release Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call on Wednesday, March 7, 2018
finance.yahoo.com - February 21 at 8:15 AM
NanoString Technologies (NSTG) Scheduled to Post Quarterly Earnings on TuesdayNanoString Technologies (NSTG) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - February 20 at 4:14 AM
NanoString Technologies Inc (NSTG) Given Average Rating of "Hold" by AnalystsNanoString Technologies Inc (NSTG) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - February 14 at 11:06 AM
NanoString Technologies Inc (NSTG) Expected to Announce Quarterly Sales of $30.32 MillionNanoString Technologies Inc (NSTG) Expected to Announce Quarterly Sales of $30.32 Million
www.americanbankingnews.com - February 14 at 5:06 AM
NanoString Showcases Groundbreaking New Platforms at 2018 Advances in Genome Biology and Technology (AGBT) ConferenceNanoString Showcases Groundbreaking New Platforms at 2018 Advances in Genome Biology and Technology (AGBT) Conference
finance.yahoo.com - February 12 at 9:06 AM
NanoString Technologies (NSTG) Says Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical OncologyNanoString Technologies (NSTG) Says Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical Oncology
www.streetinsider.com - February 7 at 8:51 AM
NanoString Announces Largest and Most Comprehensive Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical OncologyNanoString Announces Largest and Most Comprehensive Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical Oncology
finance.yahoo.com - February 6 at 8:49 AM
NanoString Technologies (NSTG) Lowered to Strong Sell at ValuEngineNanoString Technologies (NSTG) Lowered to Strong Sell at ValuEngine
www.americanbankingnews.com - February 4 at 7:40 PM
Zacks: Analysts Expect NanoString Technologies Inc (NSTG) Will Post Earnings of -$0.43 Per ShareZacks: Analysts Expect NanoString Technologies Inc (NSTG) Will Post Earnings of -$0.43 Per Share
www.americanbankingnews.com - January 26 at 1:24 PM
New Research: Key Drivers of Growth for NanoString Technologies, Oaktree Capital Group, Midstates Petroleum, GlycoMimetics, State Street, and Retail Properties of America — Factors of Influence, Major Initiatives and Sustained ProductionNew Research: Key Drivers of Growth for NanoString Technologies, Oaktree Capital Group, Midstates Petroleum, GlycoMimetics, State Street, and Retail Properties of America — Factors of Influence, Major Initiatives and Sustained Production
finance.yahoo.com - January 26 at 8:37 AM
NanoString Reports Inducement Grant Under NASDAQ Listing RulesNanoString Reports Inducement Grant Under NASDAQ Listing Rules
finance.yahoo.com - January 20 at 9:31 AM
NanoString Appoints Thomas Bailey as Chief Financial OfficerNanoString Appoints Thomas Bailey as Chief Financial Officer
finance.yahoo.com - January 16 at 9:29 AM
$30.32 Million in Sales Expected for NanoString Technologies Inc (NSTG) This Quarter$30.32 Million in Sales Expected for NanoString Technologies Inc (NSTG) This Quarter
www.americanbankingnews.com - January 11 at 7:02 AM
 Brokerages Anticipate NanoString Technologies Inc (NSTG) Will Announce Earnings of -$0.48 Per Share Brokerages Anticipate NanoString Technologies Inc (NSTG) Will Announce Earnings of -$0.48 Per Share
www.americanbankingnews.com - January 9 at 11:34 AM
NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017
finance.yahoo.com - January 8 at 9:48 AM
NanoString Technologies (NSTG) Stock Rating Upgraded by Zacks Investment ResearchNanoString Technologies (NSTG) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - January 3 at 1:20 PM
NanoString Technologies, Inc. :NSTG-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018NanoString Technologies, Inc. :NSTG-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018
finance.yahoo.com - January 1 at 9:24 AM
Head to Head Review: NanoString Technologies (NSTG) vs. IRIS International (IRIS)Head to Head Review: NanoString Technologies (NSTG) vs. IRIS International (IRIS)
www.americanbankingnews.com - December 29 at 1:18 PM
ETFs with exposure to NanoString Technologies, Inc. : December 28, 2017ETFs with exposure to NanoString Technologies, Inc. : December 28, 2017
finance.yahoo.com - December 28 at 4:46 PM
NanoString Technologies Inc (NSTG) Given Consensus Rating of "Hold" by AnalystsNanoString Technologies Inc (NSTG) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - December 26 at 9:52 AM
NanoString Technologies Inc (NSTG) Expected to Announce Earnings of -$0.48 Per ShareNanoString Technologies Inc (NSTG) Expected to Announce Earnings of -$0.48 Per Share
www.americanbankingnews.com - December 24 at 1:08 AM
Analyzing IRIS International (IRIS) and NanoString Technologies (NSTG)Analyzing IRIS International (IRIS) and NanoString Technologies (NSTG)
www.americanbankingnews.com - December 22 at 1:18 AM
NanoString Technologies Inc (NASDAQ:NSTG): Should The Recent EPS Drop Worry You?NanoString Technologies Inc (NASDAQ:NSTG): Should The Recent EPS Drop Worry You?
finance.yahoo.com - December 19 at 5:21 PM
NanoString Technologies Highlights Advances in Precision Oncology at the 59th Annual Meeting of the American Society of HematologyNanoString Technologies Highlights Advances in Precision Oncology at the 59th Annual Meeting of the American Society of Hematology
finance.yahoo.com - December 17 at 9:28 AM
IRIS International (IRIS) versus NanoString Technologies (NSTG) Head-To-Head SurveyIRIS International (IRIS) versus NanoString Technologies (NSTG) Head-To-Head Survey
www.americanbankingnews.com - December 15 at 11:08 AM
$30.19 Million in Sales Expected for NanoString Technologies, Inc. (NSTG) This Quarter$30.19 Million in Sales Expected for NanoString Technologies, Inc. (NSTG) This Quarter
www.americanbankingnews.com - December 8 at 12:06 PM
 Brokerages Expect NanoString Technologies, Inc. (NSTG) Will Post Earnings of -$0.48 Per Share Brokerages Expect NanoString Technologies, Inc. (NSTG) Will Post Earnings of -$0.48 Per Share
www.americanbankingnews.com - December 6 at 8:04 AM
NanoString Technologies, Inc. (NSTG) Given Consensus Recommendation of "Hold" by AnalystsNanoString Technologies, Inc. (NSTG) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - December 1 at 3:52 PM
Head to Head Analysis: IRIS International (IRIS) vs. NanoString Technologies (NSTG)Head to Head Analysis: IRIS International (IRIS) vs. NanoString Technologies (NSTG)
www.americanbankingnews.com - December 1 at 7:59 AM
NanoString Highlights Record Number of nCounter-Based Research Abstracts at the 2017 Annual Meeting of the Society of Immunotherapy of Cancer (SITC)NanoString Highlights Record Number of nCounter-Based Research Abstracts at the 2017 Annual Meeting of the Society of Immunotherapy of Cancer (SITC)
finance.yahoo.com - November 28 at 5:22 PM
NanoString Technologies, Inc. (NSTG) Expected to Post Quarterly Sales of $30.19 MillionNanoString Technologies, Inc. (NSTG) Expected to Post Quarterly Sales of $30.19 Million
www.americanbankingnews.com - November 20 at 11:04 AM
 Brokerages Expect NanoString Technologies, Inc. (NSTG) to Post -$0.48 EPS Brokerages Expect NanoString Technologies, Inc. (NSTG) to Post -$0.48 EPS
www.americanbankingnews.com - November 18 at 1:32 PM
NanoString Technologies, Inc. (NSTG) Receives Consensus Recommendation of "Hold" from BrokeragesNanoString Technologies, Inc. (NSTG) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 6 at 10:34 AM
NanoString Technologies, Inc. (NSTG) Price Target Lowered to $12.00 at Robert W. BairdNanoString Technologies, Inc. (NSTG) Price Target Lowered to $12.00 at Robert W. Baird
www.americanbankingnews.com - November 5 at 8:22 AM
NanoString Technologies, Inc. to Host Earnings CallNanoString Technologies, Inc. to Host Earnings Call
finance.yahoo.com - November 4 at 8:13 AM
NanoString Technologies Releases Operating Results for Third Quarter of 2017NanoString Technologies Releases Operating Results for Third Quarter of 2017
finance.yahoo.com - November 4 at 8:13 AM
Edited Transcript of NSTG earnings conference call or presentation 2-Nov-17 8:30pm GMTEdited Transcript of NSTG earnings conference call or presentation 2-Nov-17 8:30pm GMT
finance.yahoo.com - November 4 at 8:13 AM
NanoString Technologies, Inc. (NSTG) Announces Quarterly  Earnings ResultsNanoString Technologies, Inc. (NSTG) Announces Quarterly Earnings Results
www.americanbankingnews.com - November 3 at 7:02 PM
NanoString Technologies, Inc. (NSTG) Issues FY17 Earnings GuidanceNanoString Technologies, Inc. (NSTG) Issues FY17 Earnings Guidance
www.americanbankingnews.com - November 2 at 7:32 PM
Is NanoString Technologies Inc (NSTG) Undervalued?Is NanoString Technologies Inc (NSTG) Undervalued?
finance.yahoo.com - November 1 at 7:02 AM
 Brokerages Expect NanoString Technologies, Inc. (NSTG) to Post -$0.57 Earnings Per Share Brokerages Expect NanoString Technologies, Inc. (NSTG) to Post -$0.57 Earnings Per Share
www.americanbankingnews.com - October 28 at 9:10 PM
NanoString and the NSABP Foundation Enter into Agreement to Study Immunophenotypes in Colorectal CancerNanoString and the NSABP Foundation Enter into Agreement to Study Immunophenotypes in Colorectal Cancer
finance.yahoo.com - October 27 at 8:43 AM
NanoString Technologies, Inc. (NSTG) Receives "Buy" Rating from Robert W. BairdNanoString Technologies, Inc. (NSTG) Receives "Buy" Rating from Robert W. Baird
www.americanbankingnews.com - October 24 at 4:50 PM
NanoString Technologies, Inc. (NSTG) Set to Announce Earnings on TuesdayNanoString Technologies, Inc. (NSTG) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - October 24 at 12:50 PM
ETFs with exposure to NanoString Technologies, Inc. : October 23, 2017ETFs with exposure to NanoString Technologies, Inc. : October 23, 2017
finance.yahoo.com - October 24 at 7:49 AM
NanoString Technologies, Inc. (NSTG) Lowered to Market Perform at Cowen and CompanyNanoString Technologies, Inc. (NSTG) Lowered to Market Perform at Cowen and Company
www.americanbankingnews.com - October 15 at 8:30 AM
Janney Montgomery Scott Lowers NanoString Technologies, Inc. (NSTG) to NeutralJanney Montgomery Scott Lowers NanoString Technologies, Inc. (NSTG) to Neutral
www.americanbankingnews.com - October 14 at 9:00 PM
NanoString Technologies (NSTG) Falls After Lower Q3 OutlookNanoString Technologies (NSTG) Falls After Lower Q3 Outlook
www.streetinsider.com - October 13 at 7:32 AM
NanoString Technologies, Inc. (NSTG) Price Target Cut to $19.00NanoString Technologies, Inc. (NSTG) Price Target Cut to $19.00
www.americanbankingnews.com - October 12 at 10:38 PM
NanoString Technologies, Inc. (NSTG) Receives Consensus Rating of "Hold" from AnalystsNanoString Technologies, Inc. (NSTG) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - October 12 at 1:18 PM

SEC Filings

NanoString Technologies (NASDAQ:NSTG) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

NanoString Technologies (NASDAQ:NSTG) Income Statement, Balance Sheet and Cash Flow Statement

Chart

NanoString Technologies (NASDAQ NSTG) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.